STRATA SKIN SCIENCES, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$9M↓-3.0%
2025-09-30$7M↓-21.2%$-2M↑+21.8%-16.9%
2025-06-30$8M↓-9.2%$-3M↓-2729.7%-30.1%
2025-03-31$7M↑+0.9%$-2M↑+37.0%-25.0%
2024-12-31$10M↑+10.2%
2024-09-30$9M↓-0.6%$-2M↓-97.0%-18.2%
2024-06-30$8M↑+2.2%$-91K↑+97.1%-5.7%
2024-03-31$7M↓-10.7%$-3M↓-18.7%-42.7%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$9M
↓-3.0% -$284K YoY
Net Income
$4M
↑+8.5% +$330K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 63 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+0.2pts
60.4%
Operating Margin↑+1.3pts
-16.9%
Net Margin↑+0.2pts
-23.4%

Go deeper